Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2011-005790-23Phase 2Unknown
Phase 2, randomised, open-label trial of prednisolone and hydrocortisone in arthritis, hypoadrenocorticism and Corticosteroid dependence (3 arms), sponsored by Birmingham Children's Hospital. Primary endpoint: Time to adrenal recovery. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2011-005790-23.